Pharmacovigilance Market to reach USD 18.52 billion by 2032 with CAGR 11.09%
The pharmacovigilance market is focused on ensuring drug safety and efficacy by meticulously monitoring and evaluating pharmaceutical products post-market release. This crucial process involves identifying, assessing, understanding, and preventing adverse drug reactions or other drug-related issues. By prioritizing patient safety and optimizing drug benefits, pharmacovigilance plays a pivotal role in enhancing overall healthcare outcomes.